Loading...
Header Logo
Keywords
Last Name
Institution

Gopal Pathuri

TitleAsoc,Research
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentMedicine Hematology/Oncology
Phone405/271-6593
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Benbrook DM, Janakiram NB, Chandra V, Pathuri G, Madka V, Stratton NC, Masamha CP, Farnsworth CN, Garcia-Contreras L, Hatipoglu MK, Lighfoot S, Rao CV. Development of a dietary formulation of the SHetA2 chemoprevention drug for mice. Invest New Drugs. 2018 08; 36(4):561-570. PMID: 29273857.
      View in: PubMed
    2. Babu A, Amreddy N, Muralidharan R, Pathuri G, Gali H, Chen A, Zhao YD, Munshi A, Ramesh R. Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy. Sci Rep. 2017 11 07; 7(1):14674. PMID: 29116098.
      View in: PubMed
    3. Mohammed A, Janakiram NB, Madka V, Pathuri G, Li Q, Ritchie R, Biddick L, Kutche H, Zhang Y, Singh A, Gali H, Lightfoot S, Steele VE, Suen CS, Rao CV. Lack of chemopreventive effects of P2X7R inhibitors against pancreatic cancer. Oncotarget. 2017 Nov 17; 8(58):97822-97834. PMID: 29228654.
      View in: PubMed
    4. Pathuri G, Hedrick AF, Awasthi V, Cowley BD, Gali H. Synthesis and in vivo evaluation of ortho-[(124)I]iodohippurate for PET renography in healthy rats. Appl Radiat Isot. 2016 Sep; 115:251-255. PMID: 27434486.
      View in: PubMed
    5. Rao CV, Janakiram NB, Madka V, Kumar G, Scott EJ, Pathuri G, Bryant T, Kutche H, Zhang Y, Biddick L, Gali H, Zhao YD, Lightfoot S, Mohammed A. Small-Molecule Inhibition of GCNT3 Disrupts Mucin Biosynthesis and Malignant Cellular Behaviors in Pancreatic Cancer. Cancer Res. 2016 04 01; 76(7):1965-74. PMID: 26880801.
      View in: PubMed
    6. Pathuri G, Hedrick AF, Awasthi V, Cowley BD, Gali H. Evaluation of [¹8F]PFH PET renography to predict future disease progression in a rat model of autosomal dominant polycystic kidney disease. Nucl Med Biol. 2016 Jan; 43(1):1-5. PMID: 26702780.
      View in: PubMed
    7. Pathuri G, Hedrick AF, January SE, Galbraith WK, Awasthi V, Arnold CD, Cowley BD, Gali H. Synthesis and in vivo evaluation of gallium-68-labeled glycine and hippurate conjugates for positron emission tomography renography. J Labelled Comp Radiopharm. 2015 Jan; 58(1):14-9. PMID: 25545452.
      View in: PubMed
    8. Pathuri G, Madka V, Hedrick AF, Lightfoot SA, Awasthi V, Cowley BD, Rao CV, Gali H. Evaluation of (99m)Tc-probestin SPECT as a novel technique for noninvasive imaging of kidney aminopeptidase N expression. Mol Pharm. 2014 Aug 04; 11(8):2948-53. PMID: 24988047.
      View in: PubMed
    9. Pathuri G, Li Q, Mohammed A, Gali H, Pento JT, Rao CV. Synthesis and in vivo evaluation of N-ethylamino-2-oxo-1,2-dihydro-quinoline-3-carboxamide for inhibition of intestinal tumorigenesis in APC(Min/+) mice. Bioorg Med Chem Lett. 2014 Mar 01; 24(5):1380-2. PMID: 24507628.
      View in: PubMed
    10. Janakiram NB, Mohammed A, Brewer M, Bryant T, Biddick L, Lightfoot S, Pathuri G, Gali H, Rao CV. Raloxifene and antiestrogenic gonadorelin inhibits intestinal tumorigenesis by modulating immune cells and decreasing stem-like cells. Cancer Prev Res (Phila). 2014 Mar; 7(3):300-9. PMID: 24431404.
      View in: PubMed
    11. Pathuri G, Hedrick AF, Awasthi V, Ihnat MA, Gali H. Evaluation of 99mTc-probestin for imaging APN expressing tumors by SPECT. Bioorg Med Chem Lett. 2013 Sep 15; 23(18):5049-52. PMID: 23937983.
      View in: PubMed
    12. Pathuri G, Thorpe JE, Disch BC, Bailey-Downs LC, Ihnat MA, Gali H. Solid phase synthesis and biological evaluation of probestin as an angiogenesis inhibitor. Bioorg Med Chem Lett. 2013 Jun 15; 23(12):3561-4. PMID: 23664876.
      View in: PubMed
    13. Pathuri G, Hedrick AF, Awasthi V, Gali H. Single-step radiosynthesis and in vivo evaluation of a novel fluorine-18 labeled hippurate for use as a PET renal agent. Nucl Med Biol. 2012 Nov; 39(8):1195-201. PMID: 22898317.
      View in: PubMed
    14. Pathuri G, Hedrick AF, Disch BC, Ihnat MA, Awasthi V, Gali H. Synthesis and biodistribution studies of technetium-99m-labeled aminopeptidase N inhibitor conjugates. Bioorg Med Chem Lett. 2012 Jul 15; 22(14):4567-70. PMID: 22727671.
      View in: PubMed
    15. Pathuri G, Hedrick AF, Disch BC, Doan JT, Ihnat MA, Awasthi V, Gali H. Synthesis and evaluation of novel Tc-99m labeled probestin conjugates for imaging APN/CD13 expression in vivo. Bioconjug Chem. 2012 Jan 18; 23(1):115-24. PMID: 22148582.
      View in: PubMed
    16. Pathuri G, Sahoo K, Awasthi V, Gali H. Renogram comparison of p-[(18)F]fluorohippurate with o-[(125)I]iodohippurate and [(99m)Tc]MAG3 in normal rats. Nucl Med Commun. 2011 Oct; 32(10):908-12. PMID: 21876402.
      View in: PubMed
    17. Awasthi V, Pathuri G, Agashe HB, Gali H. Synthesis and in vivo evaluation of p-18F-Fluorohippurate as a new radiopharmaceutical for assessment of renal function by PET. J Nucl Med. 2011 Jan; 52(1):147-53. PMID: 21149490.
      View in: PubMed
    18. Doblas S, Pathuri G, Towner RA, Gali H. Feasibility Evaluation of Detecting Hydroxymethylphosphine Oxide In Vivo by (31)P-MRS. Int J Biomed Sci. 2010 Sep; 6(3):228-32. PMID: 23675197.
      View in: PubMed
    19. Pathuri G, Sahoo K, Awasthi V, Gali H. Synthesis and in vivo evaluation of Tc-99m-labeled cyclic CisoDGRC peptide conjugates for targeting avß3 integrin expression. Bioorg Med Chem Lett. 2010 Oct 15; 20(20):5969-72. PMID: 20829039.
      View in: PubMed
    Pathuri's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Same Department Expand Description